Conjunctivitis / Mycoplasmosis

Conjunctivitis and mycoplasmosis represent significant infectious diseases affecting canaries, finches, and related passerine birds, characterized primarily by inflammation and infection of the eyes and associated respiratory structures. The most notable form of this disease complex is caused by Mycoplasma gallisepticum, which emerged dramatically in wild House Finches in North America during the 1990s and has since spread extensively through wild finch populations while also affecting captive birds. In canaries and cage-raised finches, conjunctivitis may result from Mycoplasma infection or from various other bacterial causes, but the clinical presentation and management approaches share many similarities. These infections cause significant welfare concerns and can be fatal in severe cases, making early recognition and treatment essential.

The development of mycoplasmal conjunctivitis occurs when susceptible birds become infected through direct contact with infected individuals or through exposure to contaminated surfaces, particularly at feeding stations where birds congregate. Mycoplasma species are bacteria that lack a cell wall, making them somewhat unusual among pathogens and affecting which antibiotics are effective against them. Once a bird is infected, the organisms colonize the conjunctivae (the membranes covering the eyes), the sinuses, and upper respiratory tract. The bacteria multiply in these tissues and trigger inflammatory responses that produce the characteristic swelling, redness, and discharge observed in affected birds. Infected birds can shed organisms for extended periods, remaining sources of infection even after apparent recovery.

The impact of conjunctivitis and mycoplasmosis on affected birds ranges from mild eye irritation that resolves spontaneously to severe disease causing blindness and death. In mild cases, birds may show only slight eye redness or watering that clears within days to weeks. Moderate cases involve obvious swelling around the eyes, crusty discharge, and temporary visual impairment that interferes with feeding and predator avoidance. Severe cases progress to complete closure of the eyes, inability to eat, rapid weight loss, and death from starvation, predation, or secondary infections. The severity depends on the virulence of the infecting strain, the bird's immune status, environmental stress, and whether treatment is provided.

Treatment for conjunctivitis and mycoplasmosis is available and can be effective, particularly when initiated early before severe tissue damage occurs. Antibiotics targeting Mycoplasma, including tetracyclines and fluoroquinolones, are commonly used, along with supportive care to maintain hydration and nutrition while the bird recovers. For captive birds, treatment can significantly improve outcomes, though infected birds may remain carriers capable of transmitting disease even after clinical signs resolve. Prevention through quarantine of new birds, hygiene practices, and avoiding exposure to potentially infected wild birds represents the most effective approach. An avian veterinarian can confirm diagnosis, recommend appropriate treatment, and advise on measures to protect other birds in the collection.

The primary cause of mycoplasmosis in finches is infection with Mycoplasma gallisepticum, a small, wall-less bacterium that has naturally infected poultry for decades and emerged in wild House Finches in 1994. This organism, sometimes abbreviated as MG, spread rapidly through wild finch populations in eastern North America and has subsequently been detected in various finch species across the continent. The bacteria's lack of a cell wall makes it resistant to antibiotics like penicillins that target cell wall synthesis, while being susceptible to other antibiotic classes. Other Mycoplasma species can cause similar disease in various bird species, and bacterial conjunctivitis from non-mycoplasmal organisms also occurs in finches and canaries.

Genetic and species-related factors influence susceptibility to mycoplasmal conjunctivitis. House Finches appear particularly susceptible to Mycoplasma gallisepticum, with the dramatic epidemic in this species highlighting their vulnerability. American Goldfinches, Purple Finches, Evening Grosbeaks, and other native North American finches have also been affected. European finches including goldfinches and siskins may be susceptible when exposed. Canaries can develop conjunctivitis from various bacterial causes and may be susceptible to Mycoplasma species. Within susceptible species, individual variation in disease severity exists, with some birds developing mild self-limiting disease while others experience severe illness from similar exposure.

Environmental and husbandry factors play crucial roles in transmission and disease expression. Mycoplasma gallisepticum spreads primarily through direct contact between birds and through contaminated surfaces, particularly bird feeders and water sources where infected birds congregate. Close proximity in aviaries or cages facilitates transmission between captive birds. Poor hygiene allowing accumulation of infectious secretions on surfaces increases exposure risk. Stress from overcrowding, breeding, molting, temperature extremes, or concurrent illness suppresses immune function and increases susceptibility to infection and severe disease. Seasonal patterns with higher disease prevalence during migration and winter feeding concentrations reflect increased bird contact at feeders.

Risk factors for developing clinical conjunctivitis include exposure to infected individuals, immune status, and environmental conditions. Birds that share feeding stations with wild finches face exposure risk, particularly in areas where Mycoplasma gallisepticum is endemic. Captive birds introduced from unknown sources may be carriers. Young birds and those with compromised immune systems from stress or concurrent illness are more likely to develop severe disease. Overcrowded conditions and poor hygiene increase both exposure and disease severity. Seasonal factors including cold temperatures and reduced food availability may contribute to disease expression by increasing stress and forcing birds to congregate at feeding sites.

The mechanism of disease development involves colonization of ocular and respiratory tissues followed by inflammation that progressively damages affected structures. After exposure, Mycoplasma organisms attach to the epithelial cells lining the conjunctivae, sinuses, and upper respiratory tract. The bacteria replicate on these surfaces and trigger immune responses that cause inflammation, characterized by redness, swelling, and increased secretion production. As inflammation progresses, the conjunctivae swell and the periorbital tissues become edematous, potentially causing partial or complete closure of the eye. Sinus involvement causes facial swelling. Secondary bacterial infections can develop in damaged tissues. In severe cases, the eye itself may be damaged, and systemic effects of chronic infection lead to debilitation and death.

Early warning signs of conjunctivitis and mycoplasmosis may be subtle and easily overlooked. The first indication is often slight redness of the conjunctival membranes, visible as pink or red coloration around the eye that is more prominent than normal. The bird may blink or squint slightly more than usual or scratch at the face with its feet. A slight clear discharge from one or both eyes may develop. At this early stage, the bird typically maintains normal appetite and activity, making detection challenging without careful observation. Because birds hide illness, early signs are easily missed until more obvious symptoms develop.

Common symptoms of established conjunctivitis become increasingly apparent as the infection progresses. The eyes and surrounding tissues swell, giving the bird a puffy-faced appearance. Discharge from the eyes becomes more obvious, ranging from watery to thick and crusty depending on the stage and whether secondary infection is present. The eyelids may stick together, particularly after rest periods, requiring the bird to struggle to open its eyes. Birds may show difficulty seeing, with impaired ability to find food, navigate the cage, or avoid obstacles. In birds with respiratory involvement, nasal discharge and sneezing may also occur. The characteristic swelling around the eyes creates a distinctive appearance in affected birds.

Behavioral changes in birds with conjunctivitis reflect both the discomfort and the visual impairment caused by the infection. Affected individuals may spend more time rubbing their faces against perches or scratching at their eyes with their feet in attempts to relieve irritation. Activity levels often decrease, with birds becoming less mobile and spending more time resting. Appetite may decline, partly due to general malaise and partly because visual impairment makes finding and consuming food more difficult. Social interactions change, with affected birds often becoming more isolated or less responsive to cage mates. Canaries typically stop singing as their condition worsens.

Physical signs visible to observant owners extend beyond the ocular involvement to reflect the bird's overall condition. In addition to the characteristic eye swelling and discharge, birds may appear fluffed, indicating that they are unwell and trying to conserve heat. Weight loss develops as feeding becomes difficult and metabolic demands from fighting infection increase. The feathers around the eyes and face may become soiled and matted from discharge. In severe cases, the eyes may be completely closed, with crusty material sealing the eyelids shut. The bird may hold its head in unusual positions as it attempts to compensate for visual impairment.

Symptom progression in untreated conjunctivitis typically follows a pattern of worsening ocular involvement and declining overall condition. What begins as mild eye redness evolves into obvious swelling, then progresses to partial or complete eye closure over days to weeks. Birds that cannot see well enough to feed lose weight rapidly and become increasingly weak. Secondary bacterial infections may develop, causing more severe discharge and potential systemic illness. Without treatment, severely affected birds typically die from starvation, predation (in wild birds), or complications of infection. Some birds experience apparent spontaneous recovery, though they may remain carriers and could relapse.

Emergency symptoms requiring immediate avian veterinary care include complete inability to open one or both eyes, severe facial swelling, extreme weight loss, labored breathing suggesting respiratory involvement, or any signs of systemic illness such as collapse, extreme weakness, or inability to perch. Birds that cannot eat due to visual impairment require urgent intervention to provide nutrition and fluids while treating the underlying infection. Any rapid deterioration in a bird with conjunctivitis should prompt immediate veterinary attention. The combination of starvation risk and potential for severe disease progression makes prompt treatment essential.

Initial examination for suspected conjunctivitis and mycoplasmosis begins with careful observation and physical assessment. The veterinarian evaluates the extent and character of ocular involvement, noting the degree of swelling, type of discharge, and whether one or both eyes are affected. The periorbital region (around the eyes) and sinuses are examined for swelling that might indicate more extensive involvement. The bird's overall body condition is assessed, as weight loss often accompanies significant disease. The veterinarian asks about symptom duration, exposure to other birds (including wild birds at feeders), and any other birds in the household that might be affected or at risk.

Diagnostic tests for mycoplasmosis include several approaches with varying availability and utility. Swabs from the conjunctiva and choanal slit (a structure in the roof of the mouth connected to the nasal passages) can be submitted for bacterial culture, though Mycoplasma species require special culture media and techniques not available at all laboratories. PCR (polymerase chain reaction) testing specifically for Mycoplasma gallisepticum is available and provides sensitive detection of this organism. Serology (blood testing for antibodies) can indicate exposure but may not distinguish current from past infection. Cytology examination of conjunctival swabs may reveal characteristic patterns of inflammation. In some cases, diagnosis is made presumptively based on characteristic clinical presentation in a susceptible species.

Differential diagnosis is important because several conditions can cause similar ocular symptoms. Other bacterial infections, including those caused by Chlamydia, Staphylococcus, or Pseudomonas species, can produce conjunctivitis with similar appearance. Viral infections may cause eye involvement. Trauma to the eye can cause swelling and discharge. Foreign material in the eye creates irritation mimicking infectious conjunctivitis. Nutritional deficiencies, particularly vitamin A deficiency, can affect eye health. Environmental irritants including dust, smoke, or chemical fumes can cause conjunctival inflammation. Accurate diagnosis guides appropriate treatment selection.

Diagnosis confirmation ideally combines clinical findings with laboratory identification of the causative organism. Detection of Mycoplasma gallisepticum by PCR from conjunctival or respiratory swabs provides definitive diagnosis in birds with compatible clinical signs. Positive culture for Mycoplasma also confirms the diagnosis, though this test is less widely available. In many cases, a presumptive diagnosis is made based on characteristic clinical presentation, especially in species known to be susceptible to mycoplasmal conjunctivitis. Response to appropriate antibiotic therapy supports the diagnosis. For birds that die, post-mortem examination with histopathology and testing of tissues can confirm the diagnosis and assess the extent of disease involvement.

Emergency and immediate treatment for birds with severe conjunctivitis focuses on addressing visual impairment that prevents eating while initiating antibiotic therapy. Gentle cleaning of crusted discharge from the eyelids using warm saline may allow the bird to open its eyes and feed. Severely debilitated birds may require hospitalization with fluid therapy and nutritional support through gavage feeding until they can eat independently. Warmth and a stress-free environment support recovery. In some cases, the eyes are so severely affected that significant visual impairment persists despite treatment, requiring long-term supportive care or difficult decisions about quality of life.

Medical management of conjunctivitis and mycoplasmosis centers on antibiotic therapy targeting the causative organisms. For mycoplasmal infections, antibiotics effective against wall-less bacteria are needed, with tetracyclines (such as doxycycline) and fluoroquinolones (such as enrofloxacin) being common choices. These may be administered orally, by injection, or as eye drops depending on the specific situation and veterinary preference. Treatment courses typically last two to three weeks, though some protocols are longer. For bacterial conjunctivitis from other organisms, antibiotic selection is guided by culture and sensitivity testing when available, or empirical broad-spectrum therapy when rapid treatment is needed. Topical ophthalmic antibiotics may be used in conjunction with systemic therapy.

Surgical intervention is rarely required for conjunctivitis but may occasionally be necessary in severe cases with complications. If abscesses develop in the sinuses or periorbital tissues, surgical drainage may be needed. In cases where the eye itself is severely damaged and causing ongoing pain or serving as a source of infection, enucleation (surgical removal of the eye) might be considered, though this is uncommon. Most cases are managed medically without surgical intervention.

Supportive care during treatment significantly impacts recovery outcomes. Gentle cleaning of discharge from the eyes using warm saline helps maintain comfort and visual function. Ensure the bird can locate and access food and water, as visual impairment may interfere with normal feeding. Provide soft, easily consumed foods that require minimal visual acuity to find. Maintain warmth and reduce stress to support immune function. If the bird cannot eat independently, assisted feeding may be necessary. Keep the environment clean and free from irritants such as dust or fumes that could further irritate the eyes and respiratory tract.

Alternative and complementary treatments for conjunctivitis serve as adjuncts to, rather than replacements for, appropriate antibiotic therapy in bacterial infections. Warm compresses applied gently to the eye area may provide comfort and help loosen crusted discharge. Herbal preparations sometimes marketed for eye infections lack proven efficacy against bacterial pathogens and should not replace veterinary treatment. Maintaining optimal nutrition with vitamin A-rich foods supports eye and immune health. The most important complementary approach is excellent hygiene to reduce bacterial loads in the environment and prevent reinfection or transmission to other birds.

Treatment decisions for conjunctivitis consider individual bird factors, other birds at risk, and practical concerns. For individual pet birds, aggressive treatment with appropriate antibiotics and supportive care is generally pursued. When multiple birds are affected or at risk, decisions must be made about treating all exposed birds prophylactically. The zoonotic potential of some organisms should be considered, though Mycoplasma gallisepticum does not typically infect humans. Cost of treatment is moderate, involving antibiotic medications and possibly veterinary hospitalization for severe cases. Expected outcomes with prompt treatment are generally good for mild to moderate cases, though severely affected birds may have lasting eye damage, and recovered birds may remain carriers.

The recovery timeline for conjunctivitis and mycoplasmosis varies based on disease severity and promptness of treatment. Mild cases with early treatment may show improvement within a few days, with significant resolution of swelling and discharge within one to two weeks. Moderate cases typically require two to four weeks for full clinical recovery. Severe cases with extensive tissue damage may require longer, and some birds may have permanent visual impairment despite successful treatment of the infection. The time required for a bird to regain normal feeding behavior and activity depends on how much visual function is restored during recovery.

Post-treatment care focuses on completing the antibiotic course, monitoring for relapse, and managing the bird's return to normal activities. Complete the full prescribed treatment course even if symptoms appear resolved, as premature cessation allows surviving bacteria to repopulate and potentially develop resistance. Monitor the eyes closely for any return of redness, swelling, or discharge that might indicate relapse. Ensure the bird is eating and maintaining weight normally. Minimize stress during recovery. If the bird was isolated during treatment, consider timing and precautions for returning it to contact with other birds, keeping in mind that recovered birds may still shed organisms.

Prognosis factors for conjunctivitis and mycoplasmosis relate to disease severity, timing of treatment, and individual bird factors. Birds treated early before severe tissue damage occurs generally recover fully with good vision. Those with moderate disease may have prolonged recovery but typically regain function. Severely affected birds with extensive tissue damage may have permanent visual impairment or chronic eye problems despite successful treatment of the infection. The virulence of the infecting strain affects prognosis, with some Mycoplasma strains causing more severe disease than others. Overall health status and immune function influence both initial disease severity and recovery.

The long-term outlook for birds recovered from conjunctivitis requires acknowledgment of carrier status and potential for relapse or transmission. Many birds that recover clinically continue to harbor the organism and can shed it intermittently, particularly during periods of stress. These carrier birds may experience relapses when stressed or may transmit infection to susceptible individuals without showing symptoms themselves. Management of recovered birds in collections requires decisions about isolation, breeding, and contact with other birds. Some owners choose to maintain recovered birds as isolated pets rather than risk introducing them to disease-free collections. With appropriate management, many recovered birds live normal lives, though the carrier state must be considered in collection management.

Environmental prevention of conjunctivitis and mycoplasmosis begins with reducing exposure to potentially infected birds and maintaining hygienic conditions. For birds kept outdoors or those with access to wild birds, minimize contact at feeding stations, as these are major transmission points for Mycoplasma gallisepticum in wild finch populations. Clean and disinfect feeders regularly, ideally every few days during high-use periods. Consider feeder designs that minimize crowding and contamination. For indoor captive birds, maintain clean cages with regular disinfection of food and water dishes. Ensure good ventilation without drafts. Reduce overcrowding, which promotes transmission and stress.

Quarantine protocols are essential for preventing introduction of mycoplasmal infections into healthy collections. Quarantine all new birds for a minimum of 30 days, with 60 to 90 days preferred for detecting slow-manifesting conditions. During quarantine, observe carefully for any signs of eye problems, respiratory symptoms, or other illness. House quarantine birds in a separate airspace from established birds, as respiratory pathogens can spread through aerosols. Consider testing quarantine birds for Mycoplasma species if testing is available and practical. Birds showing any signs of conjunctivitis during quarantine should not be introduced to the main collection until fully evaluated and cleared.

Dietary prevention supports immune function and overall health that helps birds resist infection. Provide a balanced, species-appropriate diet with adequate vitamins and minerals. Vitamin A is particularly important for maintaining healthy epithelial surfaces including the conjunctiva and respiratory tract. Include fresh vegetables and fruits appropriate for the species in the diet. Ensure clean, fresh water is always available. Store food properly to prevent contamination and spoilage. Good nutrition cannot prevent exposure but supports the immune response that helps birds resist or limit infection.

Health maintenance through regular veterinary care enables early detection of eye problems and other health concerns. Establish a relationship with an avian veterinarian experienced with finches and canaries. Schedule regular wellness examinations that include careful inspection of the eyes and face. Report any signs of eye redness, swelling, or discharge promptly rather than waiting to see if problems resolve. In collections where mycoplasmosis has been diagnosed previously, discuss ongoing monitoring strategies with your veterinarian. Maintain records of any health issues to help identify patterns.

Early intervention provides better outcomes when conjunctivitis is detected. At the first sign of eye redness or swelling, begin close monitoring and consider veterinary consultation. Early treatment before severe tissue damage occurs gives the best chance for full recovery. When conjunctivitis is diagnosed in one bird, assess all birds in the collection for early signs. Enhanced hygiene measures should be implemented immediately. Consider whether prophylactic treatment of exposed but asymptomatic birds is appropriate. Working closely with your avian veterinarian to develop response protocols helps ensure prompt, effective action when disease appears.

Daily management of birds with current or recent conjunctivitis requires attention to medication administration, eye care, and monitoring of recovery. Administer all prescribed medications exactly as directed by your veterinarian, whether oral antibiotics, injectable medications, or topical eye preparations. Gently clean any discharge from around the eyes using warm saline and soft gauze or cotton, being careful not to traumatize already inflamed tissues. Observe the eyes multiple times daily for improvement or worsening. Monitor appetite and ensure the bird is eating adequately, providing assistance if visual impairment interferes with feeding. Weigh the bird regularly to track nutritional status.

Home environment optimization supports recovery while reducing transmission risk to other birds. House affected birds separately from healthy individuals during the active treatment period and ideally until fully recovered. Maintain excellent hygiene in the affected bird's housing, with frequent cleaning to reduce bacterial loads. Ensure appropriate temperature without drafts, as stress from temperature extremes can impair recovery. Provide good lighting so you can observe the bird clearly and so it can maximize use of whatever vision it retains. If visual impairment is significant, consider cage modifications such as consistent food and water placement and removal of obstacles that a visually impaired bird might collide with.

Maintaining quality of life during treatment and recovery involves adapting care to the bird's capabilities while the infection resolves. If the bird cannot see well, place food and water in consistent, easily accessible locations that the bird can locate by habit or through careful exploration. Provide soft foods that are easy to consume. Minimize unnecessary stress from handling or environmental changes. However, some birds find gentle handling comforting, so respond to individual preferences. As vision improves, gradually reintroduce normal cage furniture and activities. For canaries that have stopped singing, expect that vocalizations will resume as the bird feels better.

Monitoring and ongoing care continue beyond the immediate treatment period due to the potential for carrier status and relapse. After completing treatment, continue to observe the eyes closely for any return of symptoms that might indicate relapse. Stress events such as breeding, molting, or environmental changes may trigger reactivation of latent infection, so remain vigilant during these periods. Schedule follow-up veterinary examinations as recommended. If returning the bird to contact with others, consider the risk of transmission to susceptible individuals. Keep records of the infection episode, treatment provided, and recovery progression for future reference.

Caregiver support resources help bird owners manage the challenges of treating ocular infections. Connect with other bird enthusiasts through clubs and online communities for practical advice and emotional support. Caring for birds with visual impairment can be demanding, and sharing experiences with others helps. Financial considerations for treating conjunctivitis are moderate, involving antibiotic medications and possibly veterinary visits. More intensive treatment for severe cases increases costs. Your avian veterinarian is a valuable resource for guidance on treatment decisions and long-term management of recovered birds.

House Finches (Haemorhous mexicanus) are the species most famously affected by mycoplasmal conjunctivitis, with the epidemic that began in 1994 causing dramatic population declines in eastern North America. This species appears particularly susceptible to Mycoplasma gallisepticum, with the disease spreading rapidly and causing severe illness in affected populations. The epidemic also spread to other native North American finches including American Goldfinches (Spinus tristis), Purple Finches (Haemorhous purpureus), Evening Grosbeaks (Coccothraustes vespertinus), and Pine Siskins (Spinus pinus). These species experience varying degrees of disease severity when exposed. Wild finch populations continue to experience endemic mycoplasmal conjunctivitis, with cyclical outbreaks particularly during winter when birds concentrate at feeders.

Canaries (Serinus canaria domestica) and various cage-raised finches can develop conjunctivitis from both Mycoplasma species and other bacterial causes. While Mycoplasma gallisepticum primarily affects wild North American finches, captive canaries and finches may be exposed through contact with wild birds or through introduction of infected individuals from other collections. European finches including goldfinches, siskins, and linnets kept in captivity may be susceptible to mycoplasmosis when exposed. Other passerine species show variable susceptibility to mycoplasmal and bacterial conjunctivitis based on species-specific factors and exposure history.

Screening recommendations for species at risk emphasize observation, quarantine, and prompt response to symptoms. Monitor all finches and canaries regularly for any signs of eye redness, swelling, or discharge. New birds should be carefully quarantined and observed for ocular symptoms before introduction to existing collections. In areas where Mycoplasma gallisepticum is endemic in wild finch populations, minimize exposure between captive birds and wild birds at feeders. When acquiring finches, particularly those of species known to be susceptible, inquire about any history of eye problems in the source flock. Work with your avian veterinarian to develop monitoring protocols appropriate for your specific situation and species.

Commonly co-occurring conditions with conjunctivitis and mycoplasmosis often involve the respiratory tract, as these systems are anatomically connected. Upper respiratory infections from Mycoplasma or other bacteria may accompany or precede conjunctival involvement, with sinusitis causing facial swelling and nasal discharge. Secondary bacterial infections can develop in tissues damaged by the primary infection, potentially causing more severe disease. Air sac mites may occur concurrently in finches, causing respiratory symptoms that complicate the clinical picture. Chronic stress from any source can trigger clinical disease in carrier birds, so underlying stressors or concurrent health problems should be addressed.

Conditions with similar symptoms that must be distinguished from mycoplasmal conjunctivitis include other causes of ocular swelling and discharge. Trauma to the eye from cage furniture, other birds, or foreign objects can cause localized inflammation and discharge. Bacterial conjunctivitis from organisms other than Mycoplasma may appear similar. Chlamydiosis can cause conjunctival involvement along with systemic illness. Vitamin A deficiency affects epithelial tissues including the conjunctiva, potentially causing eye problems. Environmental irritants such as dust, smoke, or chemical fumes can cause conjunctival inflammation. Distinguishing among these causes requires careful clinical assessment and often laboratory testing.

Potential complications of conjunctivitis and mycoplasmosis extend beyond the initial ocular symptoms. Chronic or severe infection can permanently damage the conjunctiva and associated structures, causing long-term eye problems even after the infection resolves. Extension to the sinuses causes sinusitis with facial swelling and chronic discharge. In severe cases, the eye itself may be damaged, leading to blindness or loss of the eye. Secondary bacterial infections can cause more serious illness than the primary Mycoplasma infection alone. Chronic disease leads to debilitation, weight loss, and susceptibility to other health problems. Carrier status following clinical recovery means the bird can transmit infection to others and may experience future relapses.